Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice

Annals of the New York Academy of Sciences

Volumn 844, Issue , 1998, Pages 122-130

  Ali, Syed F ^a,c   Itzhak, Yossef ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Div of Molecular Epidemiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; MAZINDOL; METHAMPHETAMINE; NITRIC OXIDE SYNTHASE; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING SITE; BODY TEMPERATURE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG ABUSE; ENZYME ACTIVITY; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0031847891     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb08227.x     Document Type: Conference Paper

References (35)

1. ELLISON, G., M. S. EISON, H. S. HUBERMAN & F. DANIEL. 1978. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201: 276-278.
2. SEIDEN, L. S., M. W. FISCHMAN & C. R. SCHUSTER. 1975. Long-term methamphetamine-induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1: 215-219.
3. FULLER, R. W. & S. HEMRICK-LUECKE. 1980. Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science 209: 305-307.
4. KOGAN, F. J., W. K. NICHOLS & J. W. GIBB. 1976. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36: 363-371.
5. 3H]cyanoimipramine autoradiography. Brain Res. 505: 123-129.
6. RICUARTE, G. A., C. R. SCHUSTER & L. S. SEIDEN. 1980. Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res. 193: 153-163.
7. STERANKA, L. R. & E. SANDERS-BUSH. 1980. Long-term effects of continuous exposure to amphetamine on brain dopamine concentrations and synaptosomal uptake in mice. Eur. J. Pharmacol. 65: 439-443.
8. WAGNER, G. C., G. A. RICAURTE, L. S. SEIDEN, C. R. SHUSTER, R. J. MILLER & J. WESTLEY. 1980. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181: 151-160.
9. FIBIGER, H. C. & E. G. MCGEER. 1971. Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Eur. J. Pharmacol. 16: 76-180.
10. GIBB, J. W. & F. J. KOGAN. 1979. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal hydroxylase activity. N.S. Arch. Pharm. 310: 185-187.
11. HOTCHKISS, A. J. & J. W. GIBB. 1976. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. J. Pharmacol. Exp. Then 214: 257-262.
12. ALI, S. F., G. D. NEWPORT, R. R. HOLSON, W. SLIKKER, JR. & J. F. BOWYER. 1994. Low environmental temperatures or pharmacologic agents which produce hypothermia decreases methamphetamine neurotoxicity in mice. Brain Res. 658: 33-38.
13. ALI, S. F., G. D. NEWPORT & W. SLIKKER, JR. 1996. Methamphetamine-induced dopaminergic toxicity in mice: Role of environmental temperature and pharmacological agents. Ann. N.Y. Acad. Sci. 801: 187-198.
14. MILLER, D. B. & J. P. O'CALLAGAIIAN. 1994. Environmental-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamine in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270: 752-768.
15. SONSALLA, P. K., W. J. NICKLAS & R. E. HEIKKILA. 1989. Role of excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398-400.
16. SONSALLA, P. K., D. E. RIORDAN & R. E. HEIKKILA. 1991. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Then 256: 506-512.
17. BOWYER, J. F., A. W. TANK, G. D. NEWPORT, W. SLIKKER, JR., S. F. ALI & R. R. HOLSON. 1992. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260: 17-824.
18. BOWYER, J. F., B. GOUGH, W. SLIKKER, JR., G. W. LIFE, G. D. NEWPORT & R. R. HOLSON. 1993. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol. Biochem. Behav. 44: 87-98.
19. BOWYER, J. F., D. L. DAVIE, L. SCHMUED, H. W. BROENINO, G. D. NEWPORT, W. SLIKKER, JR. & R. R. HOLSON. 1994. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268: 571-1580.
20. WEIHMULLER, F. B., S. J. O'DELL & S. J. MARSHALL. 1992. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11: 155-163.
21. O'CALLAGHAN, J. P. & D. B. MILLER. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270: 741-751.
22. GARTHWAITE, J. 1991. Glutamate, nitric oxide, and cell-cell signalling in the nervous system. Trends Neurosci. 14: 60-67.
23. SNYDER, S. H. 1992. Nitric oxide: First in a class of neurotransmitters? Science 257: 94-496.
24. BECK.MAN, J. S., T. W. BECKMAN, J. CHEN, P. M. MARSHALL & B. A. FREEMAN. 1990. Apparent hydroxy radical production by peroxinitrite: Implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. USA 87: 1621-1624.
25. ZHANG, J., V. L. DAWSON, T. M. DAWSON & S. H. SNYDER. 1994. Nitric oxide activation of poly(ADP-ribose) synthase in neurotoxicity. Science 263: 687-689.
26. ITZHAK, Y., C. GANDIA, P. L. HAUN.G & S. F. ALI. 1998. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 284: 1040-1047.
27. MOORE, P. K., R. C. BABBEDGE, P. WALLACE, Z. A. GAFFEN & S. L. HART. 1993.7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108: 96-297.
28. ITZHAK, Y. 1996. Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase. Neuropharmacology 35: 1065-1073.
29. LOWRY, O. H., N. J. ROSEBRROUGH, A. L. FARR & R. J. RANDALL. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
30. KUPERMAN, D. I., T. F. FREYALDENHOVEN, L. SCHMUED & S. F. ALI. 1997. Methamphetamine-induced hyperthermia in mice: Examination of dopamine depletion and heat shock protein induction. Brain Res. 771: 221-227.
31. SHENG, P., C. CERRUIT, S. F. ALI & J. L. CADET. 1996. Nitric oxide is a mediator of methamphetamine-induced neurotoxicity: In vitro evidence from primary cultures of mesencephalic cells. Ann. N.Y. Acad. Sci. 801: 174-186.
32. SCHULZ, J. B., R. T. MATTHEWS, M. M. K. MIQUIT, S. E. BROWNE & M. F. BEAL. 1995. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64: 936-939.
33. PRZEDBORSKI, S., V. JACKSON-LEWIS, R. YOKOYAMA, T. SHIBATA, V. L. DAWSON & T. M. DAWSON. 1996. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93: 4565-1571.
34. DI MONTE, D. A., J. E. ROYLAND, M. W. JAKOWEC & J. W. LANGATON. 1996. Role of nitric oxide in methamphetamine neurotoxicity: Protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J. Neurochem. 67: 2443-2450.
35. ITZHAK, Y. & S. F. ALI. 1996. The neuronal nitric oxide syhtase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67: 1770-1773.